| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122111 Regeneration and neogenesis of retinal visual cell otx2 gene |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121117 Anti-angiogenic compositions and methods of use |
| 06/08/2006 | US20060121088 delivering to an external portion of the body passageway a therapeutic agent such as an antiangiogenic factor from a thread; treating stenosis or restenosis for example |
| 06/08/2006 | DE102004056822A1 Neue Wirkstoffe zu Therapie, Diagnostik und Prophylaxe der Makula-Degeneration New drugs for the therapy, diagnosis and prevention of macular degeneration |
| 06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 06/08/2006 | CA2589497A1 Novel specific caspase-10 inhibitors |
| 06/08/2006 | CA2586807A1 Topical nepafenac formulations |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666068A1 Remedy for eye diseases accompanied by optic nerve injuries |
| 06/07/2006 | EP1666067A1 Drug containing chymase inhibitor as the active ingredient |
| 06/07/2006 | EP1666043A1 Product containing prostaglandin |
| 06/07/2006 | EP1666025A1 DRUG DELIVERY SYSTEM FOR SUB-TENON’S CAPSULE ADMINISTRATION OF FINE GRAINS |
| 06/07/2006 | EP1664798A2 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide |
| 06/07/2006 | EP1664047A1 Substituted indolizine 1,2,3,6,7,8 derivatives, fgfs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 06/07/2006 | EP1663987A1 Ophthalmic compositions for treating ocular hypertension |
| 06/07/2006 | EP1663961A1 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and carbamoyloxy compounds as therapeutic agents |
| 06/07/2006 | EP1663246A2 Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 06/07/2006 | EP1663230A1 Compositions comprising benzo(g)quinoline derivatives and prostaglandin derivatives |
| 06/07/2006 | EP1663144A1 Triamcinolone acetonide and anecortave acetate formulations for injection |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient |
| 06/07/2006 | EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 06/07/2006 | EP1254234B1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 06/07/2006 | EP1147113B1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 06/07/2006 | EP1071463B1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 06/07/2006 | CN1781920A Polycyclic guanine phosphodiesterase v inhibitor |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/07/2006 | CN1781539A Zijing spleen tonifying pill |
| 06/07/2006 | CN1781523A Schisandra chinensis soft capsule |
| 06/07/2006 | CN1781514A Medicinal composition for treating keratitis caused by herpes zoster |
| 06/07/2006 | CN1781493A Eye food peptide injection and its preparing method |
| 06/07/2006 | CN1781492A Use of zijing in preparing preparation for treating shortsightedness |
| 06/07/2006 | CN1258533C Antihistaminic spiro compounds |
| 06/07/2006 | CN1258379C Botulinum toxin pharmaceutical composition |
| 06/07/2006 | CN1258359C Pharmaceutical compositions |
| 06/06/2006 | US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056898 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 06/06/2006 | US7056514 Partial peptide mimetics and methods |
| 06/06/2006 | US7056509 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents |
| 06/06/2006 | CA2449892C Nutritional supplement to treat macular degeneration |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/06/2006 | CA2154572C Use of riluzole for the treatment of neuro-sida |
| 06/01/2006 | WO2006058303A2 Modulators of muscarinic receptors |
| 06/01/2006 | WO2006058080A1 Treatment of inflammatory bowel disease |
| 06/01/2006 | WO2006058063A1 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 06/01/2006 | WO2006057432A1 Conjunctival filtration bleb forming agent and use thereof |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006056823A1 Modulating retinal pigmented epithelium permeation by inhibiting or activating vegfr-1 |
| 06/01/2006 | WO2006056182A1 Novel active substances for treating, diagnosing and preventing macular degeneration |
| 06/01/2006 | WO2006031467A9 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 06/01/2006 | WO2006029487A3 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis |
| 06/01/2006 | WO2005107752A3 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 06/01/2006 | WO2004004656A3 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 06/01/2006 | US20060116518 Novel phenanthridines |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060115500 Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 06/01/2006 | CA2589439A1 Modulators of muscarinic receptors |
| 06/01/2006 | CA2589438A1 Treatment of inflammatory bowel disease |
| 06/01/2006 | CA2588599A1 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 05/31/2006 | EP1661573A1 Ophthalmic composition |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1660096A1 Cyclohexyl prostaglandin analogs as ep-4 -receptor agonists |
| 05/31/2006 | EP1660069A2 Neuroprotection protects against cellular apoptosis, neural stroke damage, alzheimer's disease and retinal degeneration |
| 05/31/2006 | EP1448181B1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 05/31/2006 | EP1328282B1 Efficient method for producing compositions enriched in anthocyanins |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1235851B1 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 05/31/2006 | CN1778201A Composition with blue aeterio, grape seed and cassia seed |
| 05/30/2006 | US7053230 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053214 Tryptase inhibitor; antiinflammatory agents |
| 05/30/2006 | US7053107 Antiproliferative agents, angiogenesis inhibitors for treating cancer, eye disorders, diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis; N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053085 EP4 receptor agonist, compositions and methods thereof |
| 05/30/2006 | US7053068 Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053044 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 05/30/2006 | US7052714 Ophthalmic adhesive preparations for percutaneous adsorption |
| 05/30/2006 | US7052688 At least one strain of hydrogen peroxide-producing lactic acid bacteria, and at least one strain of arginine-utilizing lactic acid bacteria; treatment of infections and inflammatory conditions caused by bacteria, viruses, fungi |
| 05/30/2006 | CA2354605C Diazabicyclooctane derivatives and therapeutic uses thereof |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/30/2006 | CA2251132C Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents |
| 05/30/2006 | CA2181715C Liquid ophthalmic sustained release delivery system |
| 05/26/2006 | WO2006055526A2 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 05/26/2006 | WO2006055481A1 2,3,4-substituted cyclopentanones as therapeutic agents |
| 05/26/2006 | WO2006053836A1 Active substance delivery system comprising a hydrogel atrix and microcarriers |